Trial Details
RECRUITINGBasic Information
| Clinical ID | c2632 |
|---|---|
| Identifier | NCT03183661 |
| Trial Title | A Follow-up Study to Evaluate the Safety of ALLO-ASC-CD in ALLO-ASC-CD-101 Clinical Trial |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn Disease |
| Interventions | BIOLOGICAL: ALLO-ASC-CD |
Participant Information
| Sponsor | Anterogen Co., Ltd. |
|---|---|
| City | Seoul |
| Country/Region | South Korea |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | NULL |
Time Information
| Start Date | 2016-11-16 |
|---|---|
| Primary Completion Date | 2026-12-31 |
| Completion Date | 2026-12-31 |